Evidence map›Paper›PMID 41141440›Full record

ArticleOpen forum infectious diseases2025

Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer.

M Quinn Peters, Amber L Young, Jennifer E Stolarczuk, Madeline Glad, Erik Layton, Jennifer K Logue, Nana K Minkah, Helen Y Chu, Janet A Englund, D Noah Sather and 3 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

M Quinn PetersCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Amber L YoungDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-0284-0006
Jennifer E StolarczukDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, University of Washington, Seattle, Washington, USA.
Madeline GladCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Erik LaytonDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-6409-290X
Jennifer K LogueDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-7889-8960
Nana K MinkahCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Helen Y ChuDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-8502-9600
Janet A EnglundDivision of Infectious Diseases, Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-1134-4178
D Noah SatherCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Chetan SeshadriDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-2783-7540
Alisa KachikisDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-0358-5107
Whitney E HarringtonCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-0121-978X

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Impairment of anti-Plasmodium T cell memory by type I Interferon SignalingR01AI170777 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Nana Kwaku Minkah · 2023 to 2026
$3.2M
Protection of at-risk low birth weight infants against influenza via maternal antibodyK23AI153390 · NIAID · UNIVERSITY OF WASHINGTON · PI KACHIKIS, ALISA · 2021 to 2025
$942k
NCATS NIH HHS UL1 TR002319NIAID NIH HHS K23 AI153390NIAID NIH HHS R01 AI170777
6 · The paper itself

Abstract

Background: Safe and effective vaccines are a key preventative measure to protect infants from SARS-CoV-2 infection and disease. Although mRNA vaccines induce robust antibody titers in infants, little is known about the quality of CD4 T-cell responses induced by vaccination. CD4 T-cell responses are important in orchestrating coordinated immune responses during infection and may help to limit disease severity. Methods: To characterize the CD4 T-cell response to SARS-CoV-2 mRNA vaccination in infants, we sampled blood from 13 infants before and after primary SARS-CoV-2 mRNA vaccine series; samples from 12 historical vaccinated adults were used for comparisons. Peripheral blood mononuclear cells were stimulated with spike peptide pools, and the ability of CD4 T-cells to secrete Th1, Th2, and Th17 cytokines was quantified. Measures of polyfunctionality were generated with the COMPASS algorithm. Results: We observed a significant increase in CD4 T-cells producing IL-2 (0.01% vs 0.08%, Conclusions: These data suggest that infants have restricted induction of cytokine-producing CD4 T-cells following SARS-CoV-2 mRNA vaccination relative to adults.

Indexed as

cellular immunityinfantspediatric immunitySARS-CoV-2vaccination

Identifiers

PMID41141440
PMCPMC12548799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.